Navigation Links
Scientists find new way to fight malaria drug resistance

An anti-malarial treatment that lost its status as the leading weapon against the deadly disease could be given a new lease of life, with new research indicating it simply needs to be administered differently.

The findings could revive the use of the cheap anti-malarial drug chloroquine in treating and preventing the mosquito-bourne disease, which claims the lives of more than half a million people each year around the world.

The parasite that causes malaria has developed resistance to chloroquine, but research carried out at the Australian National University (ANU) and Germany's University of Heidelberg has shown that the parasite protein that causes resistance has an Achilles' heel.

"We studied diverse versions of this protein and in all cases found that it is limited in its capacity to remove the drug from the parasite," said malaria researcher Dr Rowena Martin, from the ANU Research School of Biology.

"This means malaria could once again be treated with chloroquine if it is administered twice-daily, rather than just once a day".

Once hailed as a wonder drug, chloroquine is still used in developing nations in the South Pacific, Africa, Asia and South America, but has been withdrawn from use in many developed countries.

Dr Martin and her colleagues also revealed how the protein may have developed resistance to chloroquine.

"We found that the protein gains the ability to move chloroquine out of the parasite through one of two evolutionary pathways, but that this process is rigid one wrong turn and the protein is rendered useless," she said.

"This indicates that the protein is under conflicting pressures, which is a weakness that could be exploited in future antimalarial strategies."

Dr Martin said the findings, published in the latest Proceedings of the National Academy of Sciences of the United States of America, could be used to help millions of people in developing nations who are at risk of catching malaria.

She said that there is also potential to apply the findings to several chloroquine-like drugs that are also becoming less effective as the malaria parasite builds up resistance.

Dr Martin, however, does not recommend taking large doses of chloroquine.

"The key is to increase the frequency of chloroquine administration, for example by taking a standard dose in the morning and another at night. If you take too much all at once it can kill you," she cautions.


Contact: ANU Media Office
Australian National University

Related medicine news :

1. Stanford scientists develop playbook for reverse engineering tissue
2. Scientists unlock secrets of protein produced by disease-causing fungus
3. Kessler Foundation scientists receive Biogen Idec grant to study actual reality in MS
4. Scientists discover a number of novel genetic defects which cause oesophageal cancer
5. Scientists find potential target for treating mitochondrial disorders
6. Scientists describe gut bacteria that cause sepsis in preterm infants
7. Virginia Tech scientists out for blood when it comes to stopping malaria
8. U-M scientists slow development of Alzheimers trademark cell-killing plaques
9. NIH scientists track evolution of a superbug
10. In the lab, scientists coax E. coli to resist radiation damage
11. Let there be tissue-penetrating light: Scientists develop new nanoscale method to fight cancer
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. This is one of Joplin's most famous and beautiful concert posters. The concert ... Michigan in Ann Arbor. The According to Hawley, "It is hard to believe that ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: